Abstract

PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2013 - Volume 17, Number 5

Page(s): 356

Download in electronic PDF format for $75
  • PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Page 1

Abstract

Related Keywords

  • regulation
  • U.S. Food and Drug Administration
  • FDA
  • regulatory agency
  • compounded sterile preparations
  • quality control
  • drug safety
  • good manufacturing practices
  • good compounding practices
  • GMP
  • GCP
  • United States Pharmacopeia
  • USP

Related Categories

  • LEGAL
  • QUALITY CONTROL
  • UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2013
Pg. 356
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 210-219
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 101-111
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Author(s): Timko Robert J, Crooker Philip EM
Jan/Feb 2013
Pg. 87
PostScription: GMPs and GCPs: A Topical Comparison
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 373-380
Documentation: Records and Reports
Author(s): Akers Michael J
Sep/Oct 2013
Pg. 439
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Mar/Apr 2017
Pg. 95-102
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Author(s): Yoch Doug
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
Mar/Apr 1997
Pg. 75-77
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 453-463
Applying Quality of Design Concepts to Pharmacy Compounding
Author(s): Timko Robert J
Jan/Feb 2023
Pg. 22-23
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Author(s): Brunner Scott
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2022
Pg. 444
PreScription: Compounded Drugs Often Become Manufactured Drugs
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 180
PreScription: Compounding for Drug Shortages
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 47-49
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Author(s): Martin Matt